- Home
- INBS vs RBNE Comparison
INBS vs RBNE Comparison
Compare INBS & RBNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBS
- RBNE
- Stock Information
- Founded
- INBS 2016
- RBNE 2024
- Country
- INBS United States
- RBNE Cyprus
- Employees
- INBS N/A
- RBNE N/A
- Industry
- INBS Medical Specialities
- RBNE Marine Transportation
- Sector
- INBS Health Care
- RBNE Consumer Discretionary
- Exchange
- INBS Nasdaq
- RBNE Nasdaq
- Market Cap
- INBS 8.6M
- RBNE 8.4M
- IPO Year
- INBS N/A
- RBNE N/A
- Fundamental
- Price
- INBS $1.30
- RBNE $3.12
- Analyst Decision
- INBS
- RBNE
- Analyst Count
- INBS 0
- RBNE 0
- Target Price
- INBS N/A
- RBNE N/A
- AVG Volume (30 Days)
- INBS 86.4K
- RBNE 85.8K
- Earning Date
- INBS 05-07-2025
- RBNE 05-21-2025
- Dividend Yield
- INBS N/A
- RBNE N/A
- EPS Growth
- INBS N/A
- RBNE N/A
- EPS
- INBS N/A
- RBNE N/A
- Revenue
- INBS $3,031,405.00
- RBNE N/A
- Revenue This Year
- INBS $280.88
- RBNE N/A
- Revenue Next Year
- INBS $126.26
- RBNE N/A
- P/E Ratio
- INBS N/A
- RBNE N/A
- Revenue Growth
- INBS 23.21
- RBNE N/A
- 52 Week Low
- INBS $1.00
- RBNE $1.32
- 52 Week High
- INBS $3.04
- RBNE $24.65
- Technical
- Relative Strength Index (RSI)
- INBS 39.13
- RBNE N/A
- Support Level
- INBS $1.34
- RBNE N/A
- Resistance Level
- INBS $1.35
- RBNE N/A
- Average True Range (ATR)
- INBS 0.12
- RBNE 0.00
- MACD
- INBS 0.02
- RBNE 0.00
- Stochastic Oscillator
- INBS 57.14
- RBNE 0.00
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).